The Benzodiazepine Alprazolam Dissociates Contextual Fear from Cued Fear in Humans as Assessed by Fear-potentiated Startle

Biological Psychiatry

Volumn 60, Issue 7, 2006, Pages 760-766

  Grillon, Christian ^a   Baas, Johanna M P ^a   Pine, Daniel S ^a   Lissek, Shmuel ^a   Lawley, Megan ^a   Ellis, Valerie ^a   Levine, Jessica ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alprazolam; anxiety; benzodiazepine; context; fear; startle reflex

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; DIPHENHYDRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEAR; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SHOCK; STARTLE REFLEX; THREAT; VOLUNTEER;

ACOUSTIC STIMULATION; ADULT; ALPRAZOLAM; ANALYSIS OF VARIANCE; ANTI-ANXIETY AGENTS; ANXIETY; ASSOCIATION LEARNING; CONDITIONING, CLASSICAL; CROSS-OVER STUDIES; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENVIRONMENT; FEAR; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; REFERENCE VALUES; STARTLE REACTION;

EID: 33748905504     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.11.027     Document Type: Article

References (42)

1. Baas J.M., Grillon C., Bocker K.B., Brack A.A., Morgan III C.A., Kenemans J.L., and Verbaten M.N. Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) 161 (2002) 233-247
2. Barlow D.H. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am Psychol 55 (2000) 1247-1263
3. Bitsios P., Philpott A., Langley R.W., Bradshaw C.M., and Szabadi E. Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol 13 (1999) 226-234
4. Bocker K.B., Baas J.M., Kenemans J.L., and Verbaten M.N. Stimulus-preceding negativity induced by fear: A manifestation of affective anticipation. Int J Psychophysiol 43 (2001) 77-90
5. Cuthbert B.N., Lang J.L., Strauss C., Drobes D., Patrick C.J., and Bradley M.B. The psychophysiology of anxiety disorders: Fear memory imagery. Psychophysiology 40 (2003) 407-422
6. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol Psychiatry 44 (1998) 1239-1247
7. Davis M., Falls W.A., Campeau S., and Kim M. Fear-potentiated startle: A neural and pharmacological analysis. Behav Brain Res 58 (1993) 175-198
8. de Jong P.J., Visser S., and Merckelbach H. Startle and spider phobia: Unilateral probes and the prediction of treatment effects. J Psychophysiol 10 (1996) 150-160
9. de Jong R., Groenink L., van der Gugten J., and Olivier B. The light-enhanced startle paradigm as a putative animal model of anxiety: Effects of chlordiazepoxide, flesonoxan and fluvoxamine. Psychopharmacology (Berl) 159 (2002) 176-180
10. First M.B., Spitzer R.I., Williams J.B.W., and Gibbon M. Structured Clinical Interview for DSM-V (SCID) (1995), American Psychiatric Association, Washington, DC
11. Fish E.W., Faccidomo S.S., Gupta S.S., and Miczek K.A.K.A. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J Pharmacol Exp Ther 308 (2004) 474-480
12. Gewirtz J.C., McNish K.A., and Davis M. Lesions of the bed nucleus of the stria terminalis block sensitization of acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neuropsychopharmacol Biol Psychiatry 22 (1998) 625-648
13. Globisch J., Hamm A.O., Esteves F., and Ohman A. Fear appears fast: Temporal course of startle reflex potentiation in animal fearful subjects. Psychophysiology 36 (1999) 66-75
14. Graham S.J., Scaife J.C., Langley R.W., Bradshaw C.M., Szabadi E., Xi L., et al. Effects of lorazepam on fear-potentiated startle responses in man. J Psychopharmacol 19 (2005) 249-258
15. Grillon C., and Ameli R. Effects of threat of shock, shock electrode placement, and darkness on startle. Int J Psychophysiol 28 (1998) 223-231
16. Grillon C., Ameli R., Goddard A., Woods S., and Davis M. Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 35 (1994) 431-439
17. Grillon C., Ameli R., Woods S.W., Merikangas K., and Davis M. Fear-potentiated startle in humans: Effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology 28 (1991) 588-595
18. Grillon C., Ameli R., Woods S.W., Merikangas K., and Davis M. Measuring the time-course of anxiety using the fear-potentiated startle reflex. Psychophysiology 30 (1993) 340-346
19. Grillon C., and Baas J.M.P. Comments on the use of the startle reflex in psychopharmacological challenges: Impact of baseline startle on measurement of fear-potentiated startle. Psychopharmacology (Berl) 164 (2002) 236-238
20. Grillon C., Baas J.P., Lissek S., Smith K., and Milstein J. Anxious responses to predictable and unpredictable aversive events. Behav Neurosci 118 (2004) 916-924
21. Grillon C., and Davis M. Fear-potentiated startle conditioning in humans: Explicit and contextual cue conditioning following paired vs. unpaired training. Psychophysiology 34 (1997) 451-458
22. Grillon C., and Morgan C.A. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol 108 (1999) 134-142
23. Grillon C., Morgan C.A., Davis M., and Southwick S.M. Effect of darkness on acoustic startle in Vietnam veterans with PTSD. Am J Psychiatry 155 (1998) 812-817
24. Grillon C., Morgan C.A., Davis M., and Southwick S.M. Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44 (1998) 1027-1036
25. Grillon C., Pellowski M., Merikangas K.R., and Davis M. Darkness facilitates the acoustic startle in humans. Biol Psychiatry 42 (1997) 453-460
26. Guscott M.R., Cook G.P., and Bristow L.J. Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: A comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists. Behav Pharmacol 11 (2000) 495-504
27. Hamm A.O., and Vaitl D. Affective learning: Awareness and aversion. Psychophysiology 33 (1996) 698-710
28. Hammack S.E., Richey K.J., Watkins L.R., and Maier S.F. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci 118 (2004) 443-448
29. Hijzen T.H., Houtzager S.W., Joordens R.J., Olivier B., and Slangen J.L. Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology (Berl) 118 (1995) 150-154
30. Lang P.J., Davis M., and Ohman A. Fear and anxiety: Animal models and human cognitive psychophysiology. J Affect Disord 61 (2000) 137-159
31. Melia K.R., and Davis M. Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepan. Physiol Behav 49 (1991) 603-611
32. Odling-Smee F.J. The role of background stimuli during Pavlovian conditioning. Q J Exp Psychol 27 (1975) 201-209
33. Pole N., Neylan T.C., Best S.R., Orr S.P., and Marmar C.R. Fear-potentiated startle and posttraumatic stress symptoms in urban police officers. J Trauma Stress 16 (2003) 471-479
34. Privou C.C., Knoche A.A., Hasenöhrl R.R.U., and Huston J.J.P. The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 37 (1998) 1019-1032
35. Riba J., Rodriguez-Fornells A., Urbano G., Morte A., Antonijoan R., and Barbanoj M.J. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: A dose-response study. Psychopharmacology (Berl) 157 (2001) 358-367
36. Scaife J.J.C., Langley R.R.W., Bradshaw C.C.M., and Szabadi E.E. Diazepam suppresses the acquisition but not the expression of "fear-potentiation" of the acoustic startle response in man. J Psychopharmacol 19 (2005) 347-356
37. Spielberger C.D. Manual for the State-Trait Anxiety Inventory (1983), Consulting Psychologists Press, Palo AltoCA
38. Walker D.L., and Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17 (1997) 9375-9383
39. Walker D.L., and Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry 42 (1997) 461-471
40. Walker D.L., and Davis M. Light-enhanced startle: Further pharmacological and behavioral characterization. Psychopharmacology (Berl) 159 (2002) 304-310
41. Walker D.L., and Davis M. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: Implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164 (2002) 318-328
42. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 (2003) 199-216